NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$59.95 -2.61 (-4.17 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$59.95
Today's Range$59.23 - $61.8350
52-Week Range$51.88 - $112.25
Volume378,728 shs
Average Volume472,202 shs
Market Capitalization$1.52 billion
P/E Ratio10.90
Dividend YieldN/A
Beta0.47
Magellan Health, Inc. provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers. It also contracts with local, state, and federal governmental agencies to provide services to recipients under Medicaid, Medicare, and other government programs, such as behavioral health and EAP, as well as healthcare management and long term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs, pharmaceutical dispensing services, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNASDAQ:MGLN
Previous Symbol
CUSIP55907920
Phone602-572-6050

Debt

Debt-to-Equity Ratio0.55
Current Ratio1.72
Quick Ratio1.67

Price-To-Earnings

Trailing P/E Ratio10.90
Forward P/E Ratio16.61
P/E Growth1.73

Sales & Book Value

Annual Sales$5.84 billion
Price / Sales0.25
Cash Flow$10.1267 per share
Price / Cash Flow5.92
Book Value$53.09 per share
Price / Book1.13

Profitability

EPS (Most Recent Fiscal Year)$5.50
Net Income$110.20 million
Net Margins1.49%
Return on Equity10.93%
Return on Assets4.67%

Miscellaneous

Employees10,700
Outstanding Shares24,250,000
Market Cap$1.52 billion
OptionableOptionable

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) posted its earnings results on Wednesday, November, 7th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.28. The company earned $1.85 billion during the quarter, compared to analyst estimates of $1.85 billion. Magellan Health had a return on equity of 10.93% and a net margin of 1.49%. Magellan Health's revenue was up 30.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.64 earnings per share. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY19 earnings guidance on Friday, December, 7th. The company provided earnings per share (EPS) guidance of $3.70-4.69 for the period, compared to the Thomson Reuters consensus estimate of $4.50. The company issued revenue guidance of $7.2-7.5 billion, compared to the consensus revenue estimate of $7.11 billion.Magellan Health also updated its FY 2019 guidance to $3.70-4.69 EPS.

What price target have analysts set for MGLN?

2 Wall Street analysts have issued 12 month price targets for Magellan Health's stock. Their forecasts range from $70.00 to $72.00. On average, they expect Magellan Health's share price to reach $71.00 in the next twelve months. This suggests a possible upside of 18.4% from the stock's current price. View Analyst Price Targets for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

Media coverage about MGLN stock has trended somewhat positive on Saturday, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Magellan Health earned a news sentiment score of 1.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next few days.

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman & CEO (Age 64)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 54)
  • Mr. Daniel N. Gregoire, Gen. Counsel & Sec. (Age 62)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 37)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.51%), Vanguard Group Inc. (10.11%), Vanguard Group Inc (10.11%), FMR LLC (8.95%), Dimensional Fund Advisors LP (8.51%) and Renaissance Technologies LLC (4.13%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, JPMorgan Chase & Co., JPMorgan Chase & Co., Wells Fargo & Company MN, Bank of Montreal Can, AXA, ClariVest Asset Management LLC and Nordea Investment Management AB. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Daniel N Gregoire, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health.

Which institutional investors are buying Magellan Health stock?

MGLN stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Morgan Stanley, Bridgeway Capital Management Inc., Assenagon Asset Management S.A., Brown Advisory Inc., BlackRock Inc., SG Americas Securities LLC and Man Group plc. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $59.95.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.52 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe.

What is Magellan Health's official website?

The official website for Magellan Health is http://www.magellanhealth.com.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  273 (Vote Outperform)
Underperform Votes:  282 (Vote Underperform)
Total Votes:  555
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel